Panupong Hansrivijit | Health Professions | Best Researcher Award

Posted on by Book of Award

Dr. Panupong Hansrivijit | Health Professions | Best Researcher Award

Brigham and Women's Hospital | United States

Author Profile

Scopus

Orcid

Google Scholar

🌟 Early Academic Pursuits

Dr. Panupong Hansrivijit embarked on his medical journey at Chulalongkorn University, where he graduated with first-class honors in medicine. His passion for internal medicine and nephrology led him to pursue an internship at Thammasat University Hospital, where he gained extensive clinical experience in patient care and medical procedures. This strong academic foundation set the stage for his future endeavors in nephrology research and clinical excellence.

πŸ₯ Professional Endeavors

Dr. Hansrivijit’s medical career took him to the United States, where he completed his Internal Medicine Residency at UPMC Harrisburg. This period was crucial in shaping his skills in patient diagnosis, management, and research methodologies. Currently, he is a Nephrology Fellow at Brigham and Women’s Hospital/Massachusetts General Hospital, specializing in managing complex kidney disorders, dialysis, and transplantation. Simultaneously, he is advancing his expertise in public health through a Master of Public Health (MPH) at Harvard T.H. Chan School of Public Health.

πŸ”¬ Contributions and Research Focus

Dr. Hansrivijit has made significant contributions to the field of nephrology, particularly in chronic kidney disease, dialysis, kidney transplantation, and pharmaco-epidemiology. His research spans multiple areas, including machine learning applications in kidney disease prediction, outcomes of kidney transplant recipients, and the impact of metabolic disorders on renal health. His extensive list of publications reflects his dedication to evidence-based medicine and improving patient outcomes.

πŸ† Accolades and Recognition

Dr. Hansrivijit's groundbreaking work has earned him multiple prestigious awards, including the Best Researcher Award (2025) from both the International Environmental Awards and the International Invention Awards. His achievements also include multiple Kidney STARS Program Awards from the American Society of Nephrology, a Travel Grant Award from the International Society of Nephrology, and recognition for his contributions to global nephrology research.

🌍 Impact and Influence

Beyond his clinical and research work, Dr. Hansrivijit is an active member of the nephrology community, holding memberships in renowned organizations such as the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN). His contributions in meta-analyses, systematic reviews, and nephrology-based epidemiological research have influenced treatment strategies and policy discussions on kidney disease management worldwide.

πŸš€ Legacy and Future Contributions

With a growing portfolio of influential research and clinical expertise, Dr. Hansrivijit is set to become a leader in nephrology innovation. His future contributions will likely focus on improving dialysis techniques, optimizing transplant outcomes, and utilizing data-driven methodologies to enhance patient care. His dedication to advancing kidney health and public health policies ensures that his impact will be felt for generations to come.

Publications

  • πŸ“„ Utilization Trends of Glucose-Lowering Medications Among Adult Kidney Transplant Recipients with Type 2 Diabetes in the United States
    Author(s): Panupong Hansrivijit, Helen Tesfaye, Deborah J. Wexler, Elisabetta Patorno, Julie M. Paik
    Journal: Journal of Clinical Medicine
    Year: 2025

  • πŸ“„ A Hospice Transitions Program for Patients in the Emergency Department
    Author(s): Christopher William A. Baugh, Kei Ouchi, Jason K. Bowman, Elizabeth M. Rickerson, Mallika Lakshmi Mendu
    Journal: JAMA Network Open
    Year: 2024

  • πŸ“„ Unpacking Contributors to CKD Incidence and Progression: Time to Move Beyond Traditional Risk Factors
    Author(s): Panupong Hansrivijit, Lipika Samal, Mallika Lakshmi Mendu
    Journal: American Journal of Kidney Diseases
    Year: 2023

  • πŸ“„ Hepatitis E Virus Infection in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
    Author(s): Angkawipa Trongtorsak, Natapat Chaisidhivej, Kritika Yadav, Wisit Cheungpasitporn, Panupong Hansrivijit
    Journal: Journal of Investigative Medicine
    Year: 2022

  • πŸ“„ Renal Manifestations of Hepatitis E Among Immunocompetent and Solid Organ Transplant Recipients
    Author(s): Karthik Reddy Kovvuru, Nicholas Carbajal, Abhinandan Reddy Pakanati, Wisit Cheungpasitporn, Swetha Rani Kanduri
    Journal: World Journal of Hepatology
    Year: 2022

 

Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Posted on by Book of Award

Dr. Rengui Saxu | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

China Pharmaceutical University | China                    

Author Profile

Orcid

Early Academic Pursuits πŸŽ“

Dr. Rengui Saxu began his academic journey at Shenyang Medical College, where he pursued a degree in Clinical Medicine Science from 2012 to 2017. During his studies, he completed an internship at Shenyang Central Hospital in 2017, gaining hands-on experience in clinical practice. His academic dedication earned him the National Encouragement Scholarship and the title of Outstanding Graduate, marking his potential as a rising scholar in the field of medicine. Continuing his academic path, Dr. Saxu pursued a Master of Pharmacy Engineering at Tianjin University of Science & Technology from 2017 to 2020. During this time, he took on leadership roles, notably serving as the Head of the Academic Department of the University Graduate Association. His work in pharmacy engineering was recognized with the Zhixing Scholarship for Postgraduate Students.

Professional Endeavors πŸ…

Dr. Saxu is currently engaged in advanced research as a Ph.D. candidate in Pharmacology at China Pharmaceutical University (2021-2025). He works under the supervision of Yong Yang, a prominent figure in pharmacological research, and Harvest F. Gu, Chief Scientist at Karolinska Medical School in Sweden. His research spans crucial areas in pharmacology, focusing on drug development and the mechanisms of disease, particularly in relation to diabetes, kidney disease, and cancer.

Contributions and Research Focus πŸ”¬

Dr. Saxu's research contributions are vast, with a focus on pharmacological innovations and therapeutic interventions for diseases like diabetes and cancer. One of his notable patents is a Chinese patent for a method involving selenium-substituted axitinib, which offers anti-tumor applications. His academic publications reflect his deep involvement in cutting-edge research:

  • His studies on asymmetries in adrenal glands and their role in glucocorticoid production provide insights into diabetes-related obesity.
  • He has explored the therapeutic potential of Abelmoschus manihot (L.) in treating diabetic nephropathy via the gut-kidney axis, contributing to the advancement of herbal medicine in disease management.
  • Dr. Saxu has also investigated how Huangkui capsules inhibit aldosterone synthesis in diabetic kidney disease, a promising direction for traditional Chinese medicine.

Accolades and Recognition πŸ†

Dr. Saxu's academic excellence has been recognized through numerous prestigious awards:

  • National Encouragement Scholarship
  • Zhixing Scholarship for Postgraduate Students
  • Doctoral Research Incentive Scholarship
  • Outstanding Doctoral Scholarship

These accolades reflect his commitment to research and innovation in the field of pharmacology.

Impact and Influence 🌍

Dr. Saxu's research has had a considerable impact on the medical and pharmacological fields, particularly in the treatment of diabetes and kidney disease. His work on drug therapy and natural compound-based treatments has opened new avenues for understanding and combating complex diseases. His research not only influences medical practices in China but also has international implications, especially in areas related to drug efficacy and safety.

Legacy and Future Contributions πŸš€

Dr. Saxu’s future contributions are poised to advance pharmacological research significantly, especially in the areas of cancer therapy and chronic disease management. As a researcher under highly esteemed mentors like Yong Yang and Harvest F. Gu, his ongoing work will likely lead to breakthroughs in targeted therapies and personalized medicine. In the years to come, Dr. Saxu's work will continue to shape the landscape of pharmaceutical sciences, offering hope for more effective and less harmful treatment options. His contributions to medical research, especially in oncology and diabetes, will leave a lasting legacy in global healthcare.

 

Publications

πŸ“œ Higher Steroid Production in the Right Adrenal Gland Compared to the Left One in db/db Mice, a Model of Type 2 Diabetic Obesity

  • Authors: Rengui Saxu, Qiming Luo, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2024

πŸ“œ Asymmetries of Left and Right Adrenal Glands in Neural Innervation and Glucocorticoids Production

  • Authors: Rengui Saxu, Yong Yang, Harvest F. Gu
  • Journal: International Journal of Molecular Sciences
  • Year: 2023